Three Stocks Nobody's Talking About — But Should Be: BDC, Beauty Tech, and a CRE Dark Horse

The market's having its moment — S&P above 7,100, Nasdaq on its longest positive streak since 1992 — and retail is busy panic-buying the names they already know. Classic. While the crowd fights over table scraps from megacap earnings, here are three names worth knowing before everyone else does.

$TPVG (TriplePoint Venture Growth BDC) sits squarely in the private credit space that Jamie Dimon just softened his tone on — the Bloomberg podcast noted 97% of BDC holdings are senior secured debt at the top of the capital structure, and Apollo's John Zito called redemption fears a 'rounding error.' Under $1B market cap, TPVG lends to VC-backed growth companies and yields north of 13%. The redemption panic created a dip; the data says it's overdone.

$SKIN (BeautyHealth) is a beaten-down med-aesthetics play in a sector that just got a rocket strapped to it — the global AI beauty market is projected to hit $13 billion by 2030, and Sephora alone is running 180,000 AI skin scans per month. SKIN owns the Hydrafacial device franchise, sitting in every med-spa that's about to upsell AI diagnostics. Under $500M market cap and completely ignored. $JLL (Jones Lang LaSalle) at ~$8B is the upper edge of mid-cap and earns its spot here: Bloomberg's C-Suite Saturday segment showed premium office is above 2019 record levels while B-grade rots. JLL runs the premium side of that K-shaped recovery with 100,000 employees in 80 countries and AI already driving revenue without proportional headcount growth. That's called operating leverage, and the market's still treating it like it's 2022.

Three names, three different catalysts — the only thing they share is that nobody at your dinner party has heard of any of them. Yet.